JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow A correction has been published
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wollenberger, A.
Right arrow Articles by Karsh, M. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wollenberger, A.
Right arrow Articles by Karsh, M. L.
Journal of Pharmacology And Experimental Therapeutics, Vol. 105, Issue 4, 477-485, 1952
Copyright © 1952 by American Society for Pharmacology and Experimental Therapeutics


EFFECT OF A CARDIAC GLYCOSIDE ON THE CONTRACTION AND THE ENERGY-RICH PHOSPHATE CONTENT OF THE HEART POISONED WITH DINITROPHENOL

Albert Wollenberger 1 and Max L. Karsh 2

1 Institute of Neurophysiology, University of Copenhagen, Denmark
2 New England College of Pharmacy, Boston, Massachusetts

1. 2,4-Dinitrophenol in concentrations of the order of 10-4 molar causes a reduction of 80 to 90 per cent in the amplitude of contraction and almost complete disappearance of phosphocreatine in the excised and continuously reperfused heart of the adult guinea pig. The ATP content is not significantly changed. The automaticity is not depressed even during the development of contracture induced by dinitrophenol.

2. The positive inotropic action of ouabain is greatly weakened or completely blocked by pretreatment with 10-4 molar dinitrophenol. Moreover, small amounts of the cardiac glycoside, which normally are non-toxic and leave the energy-rich phosphate content of the heart unchanged, become highly toxic, producing arrhythmias and precipitating contracture, and cause a 50 per cent decrease in labile nucleotide phosphate. The phosphocreatine levels remain low. Coronary flow rates at this stage are within the normal range. In contrast to dinitrophenol, ouabain has no effect on aerobic phosphorylation in guinea pig heart tissue.

3. These results can be considered to provide further support for the previously proposed hypothesis that acceleration of dephosphorylation in the heart may be an effect not only of large, toxic, but also of small, ordinarily therapeutic doses of cardiac glycosides, and that the advanced stage of cardiac glycoside poisoning is characterized biochemically by an increase in the rate of breakdown of energyrich phosphate in the myocardium not matched by a corresponding increase in synthesis. They also suggest that the primary site of attack of the cardiac glycoside in the cardiac muscle fiber is probably the same both during the therapeutic and the toxic phase of their action.

Submitted on May 12, 1952







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1952 by the American Society for Pharmacology and Experimental Therapeutics.